Neurodegenerative

Nrf2 overexpression ameliorates cognitive deficits and neuronal damage in APP/PS1 mice via attenuation of Aβ deposition and neuronal ferroptosis.

Neuroscience letters

Abstract

Alzheimer's disease (AD) is characterized by amyloid-beta (Aβ) deposition, yet the mechanisms underlying Aβ-induced neuronal damage remain elusive. Emerging evidence implicates ferroptosis, an iron-dependent form of regulated cell death, in AD pathology. We hypothesized that dysfunction of the Nrf2 pathway critically links Aβ deposition to neuronal ferroptosis and cognitive decline. In this study, AD progression in APP/PS1 mice was associated with progressive cognitive impairment, Aβ accumulation, and neurodegeneration. Aged APP/PS1 mice exhibited marked suppression of the Nrf2 antioxidant pathway, accumulation of reactive oxygen species, and prominent hallmarks of ferroptosis, including elevated DMT1 and TfR expression, accompanied by reduced GPX4 and xCT expression. Remarkably, genetic overexpression of Nrf2 significantly ameliorated cognitive impairment, attenuated neuronal and synaptic loss, and concurrently reduced Aβ deposition, oxidative stress, and neuronal ferroptosis. These findings demonstrate that Aβ accumulation is associated with impaired Nrf2 signaling during AD progression, leading to oxidative stress, neuronal ferroptosis, and cognitive dysfunction. Collectively, these findings suggest that activation of the Nrf2 pathway exerts robust protective effects against AD-like pathology, highlighting its potential as a therapeutic strategy for AD.

Key Findings

  • Nrf2 pathway suppression correlates with cognitive decline, Aβ accumulation, and neuronal ferroptosis in APP/PS1 Alzheimer's disease model mice.
  • Genetic overexpression of Nrf2 ameliorates cognitive deficits, reduces neuronal and synaptic loss, and decreases Aβ deposition and oxidative stress.
  • Activation of Nrf2 pathway protects against neuronal ferroptosis and AD-like pathology, suggesting a mechanistic link between impaired Nrf2 signaling and AD progression.

Clinical Significance

Activating the Nrf2 antioxidant pathway may provide a therapeutic strategy to mitigate cognitive decline and neuronal damage in Alzheimer's disease by reducing Aβ-induced oxidative stress and ferroptosis.

Citation

Zhu Xing, Bo Jinyao, Qian Yuluet al.. Nrf2 overexpression ameliorates cognitive deficits and neuronal damage in APP/PS1 mice via attenuation of Aβ deposition and neuronal ferroptosis. Neuroscience letters. 2026-Nov-15.

DOI: 10.1016/j.neulet.2026.138733